Jan Lapins

5PUBLICATIONS
11CO-AUTHORS
Molecular targetsPredictive and prognostic markersMortality
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 10, 2025
Germline MC1R Variant Status and Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Melanoma.

Muyi Yang, Suzanne Egyhazi Brage, Jan Lapins

|Aug 25, 2025
POT1 genetic testing in melanoma-prone families in Sweden: germline variant prevalence and tumor spectrum in identified carriers.

Konstantinos Papadakis, Francesca Portelli, Karina Schultz

|Jan 08, 2025
Desmoplastic melanoma in Sweden in 2009-2022: A population-based registry study demonstrating distinctive tumour characteristics, incidence and survival trends.

Yodit Girmay, Francesca Portelli, Rasmus Mikiver

|Sep 26, 2022
Melanoma-specific survival before and after inclusion in a familial melanoma dermatologic surveillance program in CDKN2A mutation carriers and non-carriers.

Maria Pissa, Jan Lapins, Christina Sköldmark

Pageof 1